SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001801198-24-000038
Filing Date
2024-08-09
Accepted
2024-08-09 07:01:37
Documents
73
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 6-K legn-20240630.htm   iXBRL 6-K 637304
2 EX-99.1 a991earningsreleaseq22024.htm EX-99.1 159017
3 EX-99.4 legnq2pipelinechartfor6k.htm EX-99.4 2705
9 legendlogoa.jpg GRAPHIC 6967
10 legnq2pipelinechartfor6k001.jpg GRAPHIC 127903
  Complete submission text file 0001801198-24-000038.txt   4096154

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT legn-20240630.xsd EX-101.SCH 57732
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT legn-20240630_cal.xml EX-101.CAL 88847
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT legn-20240630_def.xml EX-101.DEF 90656
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT legn-20240630_lab.xml EX-101.LAB 397390
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT legn-20240630_pre.xml EX-101.PRE 260795
75 EXTRACTED XBRL INSTANCE DOCUMENT legn-20240630_htm.xml XML 447663
Mailing Address 2101 COTTONTAIL LANE SOMERSET NJ 08873
Business Address 2101 COTTONTAIL LANE SOMERSET NJ 08873 732-317-5050
Legend Biotech Corp (Filer) CIK: 0001801198 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39307 | Film No.: 241190370
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)